These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 4147280)

  • 21. [Hyperkinetic heart syndrome].
    Lohmöller G; Lydtin H
    Fortschr Med; 1971 Aug; 89(22):864-7. PubMed ID: 4403734
    [No Abstract]   [Full Text] [Related]  

  • 22. Acute circulatory effects of a beta adrenergic blocking agent (LB 46) in patients with sympathetic overstimulation.
    Dufour R; Scazziga B; Schelling JL
    Int Z Klin Pharmakol Ther Toxikol; 1970 Dec; 4(1):145-7. PubMed ID: 4395480
    [No Abstract]   [Full Text] [Related]  

  • 23. Prindolol (Visken) and alprenolol (Aptin) in angina pectoris: a comparative clinical study with special reference to ergometer working capacity tests.
    Bjerle P; Jacobsson KA
    Curr Ther Res Clin Exp; 1974 Feb; 16(2):101-16. PubMed ID: 4218804
    [No Abstract]   [Full Text] [Related]  

  • 24. A double blind drug trial of LB-46 (visken) in angina pectoris.
    Sainani GS; Mukherjee AK
    Indian Heart J; 1972 Jun; 24():Suppl 1:192-6. PubMed ID: 4581427
    [No Abstract]   [Full Text] [Related]  

  • 25. [Clinical pharmacology of the beta-adrenolytic activity of pindolol].
    Hugues FC; Julien D; Munera Y; Heams D; Marche J
    Therapie; 1976; 31(2):179-93. PubMed ID: 7858
    [No Abstract]   [Full Text] [Related]  

  • 26. Influence of beta-blockade with beta-1-selectivity or intrinsic sympathomimetic activity on some cardiorespiratory responses to exercise.
    Yonga GO; Oyuga HW; Njeru EK
    East Afr Med J; 1993 Jul; 70(7):405-8. PubMed ID: 7904931
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The effect of Tobanum (GYKI-41099) in essential circulatory hyperkinesis, studied by radiocardiography].
    Józan M; Tarján J; Wágner G; Rostás L; Lascsik L; Kovács S; Parti G
    Orv Hetil; 1981 Oct; 122(41):2547-8. PubMed ID: 6119668
    [No Abstract]   [Full Text] [Related]  

  • 28. Hydralazine and beta-adrenergic blockade in the treatment of hypertension.
    Siitonen L; Jänne J; Keyriläinen O; Koskinen P; Leskinen O; Pitkäjärvi T; Reinikainen M
    Ann Clin Res; 1974 Dec; 6(6):341-6. PubMed ID: 4155933
    [No Abstract]   [Full Text] [Related]  

  • 29. Blood pressure reactivity in the evaluation of resting blood pressure and mood responses to pindolol and propranolol in hypertensive patients.
    Potempa KM; Fogg LF; Fish AF; Kravitz HM
    Heart Lung; 1993; 22(5):383-91. PubMed ID: 8226001
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Treatment of hypertension with the beta-receptor-antagonist pindolol (Viskèn). A comparison with chlorthalidone (Hygroton)].
    Schaffalitzky de Muckadel ; Gyntelberg F
    Ugeskr Laeger; 1973 May; 135(20):971-4. PubMed ID: 4585570
    [No Abstract]   [Full Text] [Related]  

  • 31. [Antihypertensive properties of a beta blocking agent, pindolol].
    Safar M; Weiss Y; Sobel A; Lagrue G; Milliez P
    Nouv Presse Med; 1973 Nov; 2(40):2685-8. PubMed ID: 4586561
    [No Abstract]   [Full Text] [Related]  

  • 32. [Various types of beta-receptor blockers in clinical anesthesia. 3. Pindolol (LB-46)].
    Miyazaki M; Fujita T
    Masui; 1971 Jul; 20(7):589-97. PubMed ID: 4397813
    [No Abstract]   [Full Text] [Related]  

  • 33. Treatment of essential hypertension with pindolol and clopamide: problems arising from a combined beta blocker and diuretic therapy.
    Rosenfeld JB; Traub YM; Cohen L
    Curr Ther Res Clin Exp; 1974 Aug; 16(8):786-97. PubMed ID: 4217245
    [No Abstract]   [Full Text] [Related]  

  • 34. [Effect of the combination of Pindolol and clopamide in systemic arterial hypertension. A multicenter study].
    Zilenovski AM; Freire CA
    Arq Bras Cardiol; 1981 Sep; 37(3):219-24. PubMed ID: 7052028
    [No Abstract]   [Full Text] [Related]  

  • 35. Propranolol and LB 46 (prinodolol) in angina pectoris. A comparative long-term ergometric study.
    Arstila M; Kallio V; Wendelin H
    Ann Clin Res; 1973 Apr; 5(2):91-100. PubMed ID: 4201295
    [No Abstract]   [Full Text] [Related]  

  • 36. Therapy with hydrazinopyridazine, a new antihypertensive vasodilatory agent, in combination with beta-receptor blocking substances.
    Kirch W; von Gizycki C
    Int J Clin Pharmacol Ther Toxicol; 1980; 18(5):233-5. PubMed ID: 6104636
    [No Abstract]   [Full Text] [Related]  

  • 37. [Stress tests limited by the symptoms in the evaluation of drug treatment of angina pectoris].
    Broustet JP; Pic A; Laurentjoye P; Douard H; Mora B
    Arch Mal Coeur Vaiss; 1983 Feb; 76 Spec No():17-24. PubMed ID: 6134507
    [No Abstract]   [Full Text] [Related]  

  • 38. Alprenolol in angina pectoris. A clinical and ergometric study with a new beta-adrenergic blocking agent.
    Arstila M; Iisalo E; Kallio V
    Ann Clin Res; 1969 May; 1(1):13-21. PubMed ID: 4390794
    [No Abstract]   [Full Text] [Related]  

  • 39. [Psychopharmacologic treatment of cardiac neurotic patients with dipotassium chlorazepate in double-blind test].
    Schüffel W; Schaumburg C; Schäfer N
    Arzneimittelforschung; 1970 Jan; 20(1):127-30. PubMed ID: 4909438
    [No Abstract]   [Full Text] [Related]  

  • 40. [Pressor reaction of hypertonic subjects to physical exercise of submaximal intensity under the influence of beta-adrenergic block (Pindolol) (author's transl)].
    Chrástek J; Boudová L; Kavánková M; Benes K; Krízek V; Matousek O
    Sb Lek; 1973 Oct; 75(10):301-11. PubMed ID: 4759769
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.